地塞米松对晚期非小细胞肺癌化疗患者的临床效果(3)
[6]Schuler M，Yang JC，Park K，et al.Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy，erlotinib/gefitinib and afatinib：phase Ⅲ randomized LUX-Lung 5 trial.[J].AOO ......
您现在查看是摘要页，全文长 1613 字符。